查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1631514

皮膚科藥物市場規模、佔有率、趨勢分析報告：按治療方法、類型、給藥途徑、藥物類別、分銷管道、地區和細分市場分類，預測，2025-2030 年

Dermatological Drugs Market Size, Share & Trends Analysis Report By Therapy (Acne, Psoriasis, Rosacea), By Type, By Route Of Administration, By Drug Class, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

皮膚科藥物市場的成長與趨勢

根據 Grand View Research, Inc. 的一份新報告，全球皮膚病治療市場預計到 2030 年將達到 423 億美元，2025 年至 2030 年期間的複合年成長率為 10.1%。全球皮膚病藥物市場預計將成長，其促進因素包括用於檢測和治療皮膚病的醫療資源的可用性、不健康的飲食習慣導致的營養缺乏、對文明病的認知不斷提高、污染水平上升以及人口免疫力。此外，人均收入的增加和購買力的增強正在推動這一市場的發展。

預計 2022 年至 2028 年期間痤瘡領域複合年成長率將達到 10.5%。痤瘡是一種皮膚病，皮膚中的死皮和油腺被堵塞，導致斑點、粉刺，有時還會導致囊腫。此外，受感染的毛囊會導致皮膚毛孔中出現痤瘡。痤瘡會導致臉部、肩部、胸部和背部出現粉刺、黑頭和白斑等腫塊。痤瘡可以透過皮膚科醫生的有效治療治愈，同時還可以改善皮膚外觀，從而促進皮膚病藥物市場的發展。

2021 年，北美佔最大的銷售佔有率，超過 35%。美國正在為該地區市場的成長做出積極貢獻。知名醫藥供應商的存在是支持市場成長的關鍵因素之一。該地區是醫療基礎設施和先進研發活動方面推出新技術的有希望的地區之一，這將有助於創新和生產治療癌症的最佳藥物。該地區的醫療保健行業正在經歷從傳統護理向消費者主導的快速轉變，以提供診斷和基於交付的醫療保健服務。此外，醫療保健產業的藥品供應和患者的報銷政策也有助於推動該地區市場的發展。

皮膚科藥物市場報告重點

  • 乾癬領域佔據市場主導地位，2024 年的收入佔有率最大，為 50.6%。這是由於人們對該疾病的認知和對有效治療的需求。
  • 處方藥部門將在 2024 年佔據市場主導地位，佔據 61.9% 的最大收益佔有率，預計在預測期內以 10.4% 的最快複合年成長率成長。
  • 局部用藥佔市場主導地位，2024 年銷售佔有率最大，為 60.0%。
  • 皮質類固醇佔市場主導地位，2024 年銷售佔有率最大，為 30.1%。這是由於皮膚感染疾病患者的數量不斷增加以及研究和開發的成長。
  • 零售藥局將佔據市場主導地位，2024 年的銷售佔有率最大，為 50.6%。這是由於非處方皮膚病產品的成長和人們對皮膚病的認知的提高。
  • 2024 年北美皮膚病藥物市場佔據主導地位，收入佔有率最大，為 38.6%。
  • 2024 年北美皮膚病藥物市場佔最大收入佔有率，為 33.6%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. 皮膚科藥物市場變數、趨勢和範圍

  • 市場介紹/電網展望
  • 市場規模和成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 皮膚科藥物市場分析工具
    • 波特的分析
    • PESTEL 分析

第 4 章 皮膚科藥物市場：治療方法進行估計和趨勢分析

  • 2024 年和 2030 年治療方法市場佔有率
  • 治療方法細分儀表板
  • 2018 年至 2030 年按治療方法的市場規模、預測與趨勢分析
  • 粉刺
  • 乾癬
  • 酒糟樣皮膚炎
  • 脫髮症
  • 其他

第 5 章皮膚病藥物市場：按類型估計和趨勢分析

  • 2024 年及 2030 年類型市場佔有率
  • 類型細分儀表板
  • 2018 年至 2030 年按類型分類的市場規模、預測與趨勢分析
  • 處方箋
  • 場外交易（OTC）

第6章 皮膚科藥物市場：依給藥途徑的估計與趨勢分析

  • 2024 年及 2030 年給藥途徑市場佔有率
  • 給藥途徑細分儀表板
  • 2018 年至 2030 年按給藥途徑分類的市場規模、預測和趨勢分析
  • 局部給藥
  • 口服
  • 腸外給藥

7. 皮膚科藥物市場：藥物類別、估計與趨勢分析

  • 2024 年及 2030 年藥物類別市場佔有率
  • 藥品類別細分儀表板
  • 2018 年至 2030 年按藥物類別分類的市場規模、預測和趨勢分析
  • 皮質類固醇
  • 類視色素
  • 抗生素
  • 抗真菌藥物
  • Calcineurin抑制劑
  • 其他

第 8 章：皮膚科藥物市場：按分銷管道進行的估計和趨勢分析

  • 分銷通路市場佔有率，2024 年和 2030 年
  • 分銷通路細分儀表板
  • 2018 年至 2030 年按分銷管道分類的市場規模、預測和趨勢分析
  • 醫院藥房
  • 零售藥局
  • 其他

第9章皮膚科藥物市場：按地區分類的估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030 年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • AbbVie Inc.
    • Pfizer Inc.
    • GSK plc.
    • Sun Pharmaceutical Industries Ltd.
    • GALDERMA
    • Amgen Inc.
    • Johnson & Johnson Services, Inc.
    • Novartis AG
    • Eli Lilly and Company
    • Almirall, SA
    • Bausch Health Companies Inc.
Product Code: GVR-4-68039-934-2

Dermatological Drugs Market Growth & Trends:

The global dermatological drugs market size is expected to reach USD 42.3 billion by 2030, expanding at a CAGR of 10.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The global dermatological drugs market is expected to grow due to driving factors such as the availability of medical resources for detecting and treating skin diseases, nutritional deficiency due to unhealthy food habits, increasing awareness when it comes to lifestyle diseases, and increasing pollution levels, and lack of immunity in the population. Additionally, the rising per capita income and the increasing purchasing power are the driving forces in this market.

The acne segment is expected to expand with a CAGR of 10.5% from 2022 to 2028. Acne is a skin condition where dead skin and oil glands of skin glands are clogged, forming spots, pimples, and sometimes cysts. Additionally, infected hair follicles cause acne, which starts from the skin's pores. Acne causes bumps on the face, shoulders, chest, and back in the form of pimples, blackheads, and whiteheads. Acne can be cured, and the appearance of the skin can be improved with effective treatment from dermatologists, contributing to the dermatological drug market.

North America held the largest revenue share of more than 35% in 2021. The U.S. is positively contributing to the growth of the regional market. The presence of well-established pharmaceutical vendors is one of the key factors supporting the market growth. This region is one of the promising regions to launch new technology in terms of healthcare infrastructure and advanced research and development activities that help innovate and produce the most appropriate drugs to cure cancer. It is observed that in the region, there is a rapid shift in the healthcare industry to consumer-driven from traditional treatment for providing diagnosis and provision-based health services. Additionally, ease of availability of drugs and reimbursement policies for the patient in the healthcare industry contributes to driving the market in the region.

Dermatological Drugs Market Report Highlights:

  • The psoriasis segment dominated the market with the largest revenue share of 50.6% in 2024, which can be attributed to the awareness of the disease and the demand for effective treatments.
  • The prescription segment dominated the market for the largest revenue share of 61.9% in 2024 and is expected to grow over the fastest CAGR of 10.4% over the forecast period.
  • Topical administration dominated the market with the largest revenue share of 60.0% in 2024.
  • Corticosteroids dominated the market with the largest revenue share of 30.1% in 2024. This can be attributed to rising skin infection cases and the growth of research and development.
  • Retail pharmacies dominated the market, with the largest revenue share of 50.6% in 2024. This can be attributed to OTC dermatological product growth and awareness of skin conditions.
  • The dermatological drugs market in North America dominated the market with the largest revenue share of 38.6% in 2024, which can be attributed to advancements in drug development and increasing awareness.
  • The North America Dermatological Drugs market had the largest revenue share of 33.6% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Dermatological Drugs Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Dermatological Drugs Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining Power of the Suppliers
      • 3.4.1.2. Bargaining Power of the Buyers
      • 3.4.1.3. Threats of Substitution
      • 3.4.1.4. Threats from New Entrants
      • 3.4.1.5. Competitive Rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political Landscape
      • 3.4.2.2. Economic and Social Landscape
      • 3.4.2.3. Technological Landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape

Chapter 4. Dermatological Drugs Market: Therapy Estimates & Trend Analysis

  • 4.1. Therapy Market Share, 2024 & 2030
  • 4.2. Therapy Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Therapy, 2018 to 2030 (USD Million)
  • 4.4. Acne
    • 4.4.1. Acne Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Psoriasis
    • 4.5.1. Psoriasis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Rosacea
    • 4.6.1. Rosacea Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Alopecia
    • 4.7.1. Alopecia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Dermatological Drugs Market: Type Estimates & Trend Analysis

  • 5.1. Type Market Share, 2024 & 2030
  • 5.2. Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Prescription
    • 5.4.1. Prescription Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Over-the-counter (OTC)
    • 5.5.1. Over-the-counter (OTC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Dermatological Drugs Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Route of Administration Market Share, 2024 & 2030
  • 6.2. Route of Administration Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 6.4. Topical Administration
    • 6.4.1. Topical Administration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Oral Administration
    • 6.5.1. Oral Administration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Parenteral Administration
    • 6.6.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Dermatological Drugs Market: Drug Class Estimates & Trend Analysis

  • 7.1. Drug Class Market Share, 2024 & 2030
  • 7.2. Drug Class Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
  • 7.4. Corticosteroids
    • 7.4.1. Corticosteroids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Retinoids
    • 7.5.1. Retinoids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Antibiotics
    • 7.6.1. Antibiotics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Antifungals
    • 7.7.1. Antifungals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Calcineurin Inhibitors
    • 7.8.1. Calcineurin Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Others
    • 7.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Dermatological Drugs Market: Distribution Channel Estimates & Trend Analysis

  • 8.1. Distribution Channel Market Share, 2024 & 2030
  • 8.2. Distribution Channel Segment Dashboard
  • 8.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 8.4. Hospital Pharmacies
    • 8.4.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Retail Pharmacies
    • 8.5.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Dermatological Drugs Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Framework
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. U.S. Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Framework
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Canada Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Framework
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. Mexico Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Framework
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. UK Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Framework
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Germany Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Regulatory Framework
      • 9.5.4.3. Competitive Insights
      • 9.5.4.4. France Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Regulatory Framework
      • 9.5.5.3. Competitive Insights
      • 9.5.5.4. Italy Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Regulatory Framework
      • 9.5.6.3. Competitive Insights
      • 9.5.6.4. Spain Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.7. Denmark
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Regulatory Framework
      • 9.5.7.3. Competitive Insights
      • 9.5.7.4. Denmark Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key Country Dynamics
      • 9.5.8.2. Regulatory Framework
      • 9.5.8.3. Competitive Insights
      • 9.5.8.4. Sweden Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.9. Norway
      • 9.5.9.1. Key Country Dynamics
      • 9.5.9.2. Regulatory Framework
      • 9.5.9.3. Competitive Insights
      • 9.5.9.4. Norway Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. China
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Framework
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. China Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Japan
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Framework
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. Japan Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Framework
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. India Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Framework
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Australia Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Regulatory Framework
      • 9.6.6.3. Competitive Insights
      • 9.6.6.4. South Korea Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key Country Dynamics
      • 9.6.7.2. Regulatory Framework
      • 9.6.7.3. Competitive Insights
      • 9.6.7.4. Thailand Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Regulatory Framework
      • 9.7.2.3. Competitive Insights
      • 9.7.2.4. Brazil Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Regulatory Framework
      • 9.7.3.3. Competitive Insights
      • 9.7.3.4. Argentina Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.8. Middle East and Africa
    • 9.8.1. Middle East and Africa Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key Country Dynamics
      • 9.8.2.2. Regulatory Framework
      • 9.8.2.3. Competitive Insights
      • 9.8.2.4. South Africa Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key Country Dynamics
      • 9.8.3.2. Regulatory Framework
      • 9.8.3.3. Competitive Insights
      • 9.8.3.4. Saudi Arabia Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key Country Dynamics
      • 9.8.4.2. Regulatory Framework
      • 9.8.4.3. Competitive Insights
      • 9.8.4.4. UAE Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key Country Dynamics
      • 9.8.5.2. Regulatory Framework
      • 9.8.5.3. Competitive Insights
      • 9.8.5.4. Kuwait Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Overview
  • 10.2. Company Market Position Analysis
  • 10.3. Company Categorization
  • 10.4. Strategy Mapping
  • 10.5. Company Profiles/Listing
    • 10.5.1. AbbVie Inc.
      • 10.5.1.1. Participant's Overview
      • 10.5.1.2. Financial Performance
      • 10.5.1.3. Product Benchmarking
      • 10.5.1.4. Recent Developments/ Strategic Initiatives
    • 10.5.2. Pfizer Inc.
      • 10.5.2.1. Participant's Overview
      • 10.5.2.2. Financial Performance
      • 10.5.2.3. Product Benchmarking
      • 10.5.2.4. Recent Developments/ Strategic Initiatives
    • 10.5.3. GSK plc.
      • 10.5.3.1. Participant's Overview
      • 10.5.3.2. Financial Performance
      • 10.5.3.3. Product Benchmarking
      • 10.5.3.4. Recent Developments/ Strategic Initiatives
    • 10.5.4. Sun Pharmaceutical Industries Ltd.
      • 10.5.4.1. Participant's Overview
      • 10.5.4.2. Financial Performance
      • 10.5.4.3. Product Benchmarking
      • 10.5.4.4. Recent Developments/ Strategic Initiatives
    • 10.5.5. GALDERMA
      • 10.5.5.1. Participant's Overview
      • 10.5.5.2. Financial Performance
      • 10.5.5.3. Product Benchmarking
      • 10.5.5.4. Recent Developments/ Strategic Initiatives
    • 10.5.6. Amgen Inc.
      • 10.5.6.1. Participant's Overview
      • 10.5.6.2. Financial Performance
      • 10.5.6.3. Product Benchmarking
      • 10.5.6.4. Recent Developments/ Strategic Initiatives
    • 10.5.7. Johnson & Johnson Services, Inc.
      • 10.5.7.1. Participant's Overview
      • 10.5.7.2. Financial Performance
      • 10.5.7.3. Product Benchmarking
      • 10.5.7.4. Recent Developments/ Strategic Initiatives
    • 10.5.8. Novartis AG
      • 10.5.8.1. Participant's Overview
      • 10.5.8.2. Financial Performance
      • 10.5.8.3. Product Benchmarking
      • 10.5.8.4. Recent Developments/ Strategic Initiatives
    • 10.5.9. Eli Lilly and Company
      • 10.5.9.1. Participant's Overview
      • 10.5.9.2. Financial Performance
      • 10.5.9.3. Product Benchmarking
      • 10.5.9.4. Recent Developments/ Strategic Initiatives
    • 10.5.10. Almirall, S.A
      • 10.5.10.1. Participant's Overview
      • 10.5.10.2. Financial Performance
      • 10.5.10.3. Product Benchmarking
      • 10.5.10.4. Recent Developments/ Strategic Initiatives
    • 10.5.11. Bausch Health Companies Inc.
      • 10.5.11.1. Participant's Overview
      • 10.5.11.2. Financial Performance
      • 10.5.11.3. Product Benchmarking
      • 10.5.11.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Dermatological Drugs Market, by Region, 2018 - 2030 (USD Million)
  • Table 4. Global Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 5. Global Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 6. Global Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 7. Global Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 8. Global Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9. North America Dermatological Drugs Market, by Country, 2018 - 2030 (USD Million)
  • Table 10. North America Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 11. North America Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 12. North America Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 13. North America Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 14. North America Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15. U.S. Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 16. U.S. Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 17. U.S. Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 18. U.S. Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 19. U.S. Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20. Canada Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 21. Canada Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 22. Canada Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 23. Canada Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 24. Canada Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 25. Mexico Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 26. Mexico Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 27. Mexico Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 28. Mexico Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 29. Mexico Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30. Europe Dermatological Drugs Market, by Country, 2018 - 2030 (USD Million)
  • Table 31. Europe Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 32. Europe Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 33. Europe Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 34. Europe Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 35. Europe Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36. UK Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 37. UK Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 38. UK Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 39. UK Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 40. UK Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41. Germany Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 42. Germany Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 43. Germany Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 44. Germany Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 45. Germany Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46. France Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 47. France Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 48. France Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 49. France Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 50. France Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51. Italy Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 52. Italy Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 53. Italy Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 54. Italy Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 55. Italy Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56. Spain Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 57. Spain Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 58. Spain Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 59. Spain Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 60. Spain Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 61. Denmark Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 62. Denmark Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 63. Denmark Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 64. Denmark Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 65. Denmark Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66. Sweden Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 67. Sweden Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 68. Sweden Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 69. Sweden Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 70. Sweden Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 71. Norway Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 72. Norway Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 73. Norway Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 74. Norway Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 75. Norway Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76. Asia Pacific Dermatological Drugs Market, by Country, 2018 - 2030 (USD Million)
  • Table 77. Asia Pacific Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 78. Asia Pacific Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 79. Asia Pacific Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 80. Asia Pacific Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 81. Asia Pacific Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82. Japan Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 83. Japan Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 84. Japan Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 85. Japan Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 86. Japan Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87. China Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 88. China Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 89. China Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 90. China Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 91. China Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92. India Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 93. India Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 94. India Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 95. India Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 96. India Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 97. Australia Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 98. Australia Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 99. Australia Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 100. Australia Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 101. Australia Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 102. South Korea Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 103. South Korea l Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 104. South Korea Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 105. South Korea Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 106. South Korea Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 107. Thailand Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 108. Thailand Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 109. Thailand Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 110. Thailand Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 111. Thailand Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 112. Latin America Dermatological Drugs Market, by Country, 2018 - 2030 (USD Million)
  • Table 113. Latin America Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 114. Latin America Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 115. Latin America Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 116. Latin America Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 117. Latin America Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 118. Brazil Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 119. Brazil Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 120. Brazil Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 121. Brazil Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 122. Brazil Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 123. Argentina Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 124. Argentina Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 125. Argentina Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 126. Argentina Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 127. Argentina Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 128. Middle East & Africa Dermatological Drugs Market, by Country, 2018 - 2030 (USD Million)
  • Table 129. Middle East & Africa Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 130. Middle East & Africa Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 131. Middle East & Africa Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 132. Middle East & Africa Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 133. Middle East & Africa Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 134. South Africa Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 135. South Africa Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 136. South Africa Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 137. South Africa Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 138. South Africa Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 139. Saudi Arabia Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 140. Saudi Arabia Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 141. Saudi Arabia Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 142. Saudi Arabia Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 143. Saudi Arabia Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 144. UAE Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 145. UAE Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 146. UAE Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 147. UAE Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 148. UAE Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 149. Kuwait Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 150. Kuwait Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 151. Kuwait Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 152. Kuwait Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 153. Kuwait Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Dermatological Drugs Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot

Fig. 9 Segment Outlook (USD Million)

  • Fig. 10 Competitive Landscape
  • Fig. 11 Dermatological Drugs Market Dynamics
  • Fig. 12 Dermatological Drugs Market: Porter's Five Forces Analysis
  • Fig. 13 Dermatological Drugs Market: Pestle Analysis
  • Fig. 14 Dermatological Drugs Market: Therapy Segment Dashboard
  • Fig. 15 Dermatological Drugs Market: Therapy Market Share Analysis, 2024 & 2030
  • Fig. 16 Acne Market (USD Million)
  • Fig. 17 Psoriasis Market (USD Million)
  • Fig. 18 Rosacea Market (USD Million)
  • Fig. 19 Alopecia Market (USD Million)
  • Fig. 20 Others Market, 2018 - 2030 (USD Million)
  • Fig. 21 Dermatological Drugs Market: Type Segment Dashboard
  • Fig. 22 Dermatological Drugs Market: Type Market Share Analysis, 2024 & 2030
  • Fig. 23 Prescription Market (USD Million)
  • Fig. 24 Over-the-counter (OTC) Market (USD Million)
  • Fig. 25 Dermatological Drugs Market: Route of Administration Segment Dashboard
  • Fig. 26 Dermatological Drugs Market: Route of Administration Market Share Analysis, 2024 & 2030
  • Fig. 27 Topical Administration Market (USD Million)
  • Fig. 28 Oral Administration Market (USD Million)
  • Fig. 29 Parenteral Administration Market (USD Million)
  • Fig. 30 Dermatological Drugs Market: Drug Class Segment Dashboard
  • Fig. 31 Dermatological Drugs Market: Drug Class Market Share Analysis, 2024 & 2030
  • Fig. 32 Corticosteroids Market (USD Million)
  • Fig. 33 Retinoids Market (USD Million)
  • Fig. 34 Antibiotics Market (USD Million)
  • Fig. 35 Antifungals Market (USD Million)
  • Fig. 36 Calcineurin Inhibitors Market (USD Million)
  • Fig. 37 Others Market, 2018 - 2030 (USD Million)
  • Fig. 38 Dermatological Drugs Market: Distribution Channel Segment Dashboard
  • Fig. 39 Dermatological Drugs Market: Distribution Channel Market Share Analysis, 2024 & 2030
  • Fig. 40 Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig. 41 Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig. 42 Others Market, 2018 - 2030 (USD Million)
  • Fig. 43 Distance Correspondence Market, 2018 - 2030 (USD Million)
  • Fig. 44 Regional Marketplace: Key Takeaways
  • Fig. 45 North America Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. Country Dynamics
  • Fig. 47 U.S. Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 48 Canada Country Dynamics
  • Fig. 49 Canada Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico Country Dynamics
  • Fig. 51 Mexico Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 52 Europe Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 53 UK Country Dynamics
  • Fig. 54 UK Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 55 Germany Country Dynamics
  • Fig. 56 Germany Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 57 France Country Dynamics
  • Fig. 58 France Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 59 Italy Country Dynamics
  • Fig. 60 Italy Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 61 Spain Country Dynamics
  • Fig. 62 Spain Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 63 Denmark Country Dynamics
  • Fig. 64 Denmark Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 65 Sweden Country Dynamics
  • Fig. 66 Sweden Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 67 Norway Country Dynamics
  • Fig. 68 Norway Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 70 Japan Country Dynamics
  • Fig. 71 Japan Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 72 China Country Dynamics
  • Fig. 73 China Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 74 India Country Dynamics
  • Fig. 75 India Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 76 Australia Country Dynamics
  • Fig. 77 Australia Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 78 South Korea Country Dynamics
  • Fig. 79 South Korea Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 80 Thailand Country Dynamics
  • Fig. 81 Thailand Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil Country Dynamics
  • Fig. 84 Brazil Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 85 Argentina Country Dynamics
  • Fig. 86 Argentina Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 87 MEA Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 88 South Africa Country Dynamics
  • Fig. 89 South Africa Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 90 Saudi Arabia Country Dynamics
  • Fig. 91 Saudi Arabia Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 92 UAE Country Dynamics
  • Fig. 93 UAE Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 94 Kuwait Country Dynamics
  • Fig. 95 Kuwait Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 96 Company Categorization
  • Fig. 97 Company Market Position Analysis
  • Fig. 98 Strategic Framework